Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

A man developed excessive hair growth after treatment with interferon-alpha and ribavirin for hepatitis C.

Y-27632 helps hair follicle stem cells grow and keep their abilities.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Fewer GGC sequences in the androgen receptor gene improve finasteride treatment for hair loss.

High-dose iron therapy improves anemia without affecting IBD treatment.

Inositol and folic acid treatment significantly reduced hair loss and other symptoms in patients with androgenetic alopecia, but more research is needed for confirmation.

PDRN may reduce inflammation and complications in revision rhinoplasty for patients with high fibrinogen levels.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Early diagnosis of frontal fibrosing alopecia is crucial to prevent permanent hair loss.

Fractional radiofrequency microneedling is as effective and safe as intralesional steroids for treating patchy alopecia areata, with fewer side effects.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

GDNF signaling helps in hair growth and skin healing after a wound.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Frontal fibrosing alopecia in postmenopausal women can be managed with early treatment using corticosteroids to stop hair loss.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Certain proteins and their receptors are more active during the growth phase of human hair and could be targeted to treat hair disorders.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.